CHANGES IN DIURNAL AND NOCTURNAL MELATONIN LEVEL IN WOMEN WITH METABOLIC SYNDROME STRATIFIED BY THE CONCENTRATION OF SERUM TRIGLICERIDES AND HIGHT DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION Cover Image

CHANGES IN DIURNAL AND NOCTURNAL MELATONIN LEVEL IN WOMEN WITH METABOLIC SYNDROME STRATIFIED BY THE CONCENTRATION OF SERUM TRIGLICERIDES AND HIGHT DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION
CHANGES IN DIURNAL AND NOCTURNAL MELATONIN LEVEL IN WOMEN WITH METABOLIC SYNDROME STRATIFIED BY THE CONCENTRATION OF SERUM TRIGLICERIDES AND HIGHT DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION

Author(s): Vania Peneva, Mitko Mitkov, Tanya Deneva
Subject(s): Health and medicine and law
Published by: Scientific Institute of Management and Knowledge
Keywords: melatonin;leptin;ghrelin;metabolic syndrome;women

Summary/Abstract: Metabolic syndrome (MetS) is defined as a constellation of interrelated metabolic risk factors that increase the risk of developing type 2 diabetes mellitus and cardiovascular disease. According to the definitions of a number of international organizations and expert groups of MetS, dyslipidaemia is always indicated as one of the main risk factor. Objective: To compare the night and day concentrations of the hormonal parameters melatonin, leptin, ghrelin in women with MetS and we analyse their relationship according to the concentration of high-density lipoprotein (HDL)-cholesterol and the concentration of triglyceride (TG). Methods: 41 women with diagnosis MetS according to IDF consensus criteria were enrolled in our study. Melatonin samples were taken at night (02:00 am- 03:00 am; light < 10 lux) and in the morning (08:00 am - 09:00 am). A morning venous blood was drawn after 8 hours of fasting. Serum glucose, total cholesterol, TG, HDL-cholesterol, and low-density lipoprotein (LDL) cholesterol levels were analyzed according to the manufacturer's original programs (Olympys AU 480, Beckman Coulter, USA). Serum melatonin concentrations were measured using ELISA kit (Elabscience Biotechnology Inc, China), serum ghrelin (ELISA kit, Elabscience Biotechnology Inc, China) and leptin (ELISA kit IBL-Hamburg, Germany) on Sirio S micro plate reader (SEAC, Italy). Each participant provided informed consent. All data were analysed by descriptive and nonparametric analysis. Statistical significance was accepted at P < 0.05. Results: Women with TG ≥ 1.7 mmol/l did not have a statistically significant difference in age compared to women with TG < 1.7 mmol/l (t = 1.28, P = 0.209), in mean waist (t = 0.11, P = 0.916) and in mean BMI values (U = 154.50, P = 0.652). Women with TG ≥ 1.7 mmol/l have a higher average concentration of glucose and total cholesterol than women with TG < 1.7 mmol/l. The two subgroups did not differ in melatonin at 03:00am. and 08:00am and in other metabolic and hormonal parameters. Women with HDL-cholesterol < 1.3 mmol/l had a statistically significant larger waist (t = 3.45, P = 0.001) and higher BMI (U = 126.50, P = 0.029) and leptin at 08.00am (U = 134.00, P = 0.047), from women with HDL - cholesterol ≥ 1.3 mmol/l. The two subgroups did not differ in melatonin at 03:00 a. m and 8:00 a.m. and other hormonal and metabolic indicators. Conclusion: Low HDL-cholesterol and elevated TG are associated with increased waist circumference, BMI and leptin, respectively, rather than with changes in the other investigated hormonal indicators.

  • Issue Year: 64/2024
  • Issue No: 4
  • Page Range: 395-400
  • Page Count: 6
  • Language: English
Toggle Accessibility Mode